Concepts (231)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Hormones | 10 | 2019 | 68 | 1.980 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 11 | 2019 | 55 | 1.560 |
Why?
|
| Receptors, Thyroid Hormone | 8 | 2015 | 87 | 1.390 |
Why?
|
| Co-Repressor Proteins | 3 | 2015 | 38 | 0.980 |
Why?
|
| Liver | 11 | 2025 | 1850 | 0.870 |
Why?
|
| Nuclear Proteins | 6 | 2017 | 1334 | 0.680 |
Why?
|
| Thyroid Hormone Receptors beta | 5 | 2017 | 21 | 0.660 |
Why?
|
| Thyroid Gland | 4 | 2015 | 115 | 0.660 |
Why?
|
| Triiodothyronine | 5 | 2014 | 69 | 0.610 |
Why?
|
| Hypothyroidism | 4 | 2017 | 100 | 0.580 |
Why?
|
| Energy Metabolism | 4 | 2025 | 809 | 0.550 |
Why?
|
| Repressor Proteins | 4 | 2009 | 867 | 0.520 |
Why?
|
| Gene Expression Regulation | 8 | 2021 | 2656 | 0.500 |
Why?
|
| Cholesterol | 4 | 2019 | 574 | 0.480 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2015 | 71 | 0.470 |
Why?
|
| Sulfotransferases | 3 | 2004 | 28 | 0.460 |
Why?
|
| Fructose | 3 | 2021 | 62 | 0.460 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 3 | 2019 | 5 | 0.360 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 1756 | 0.340 |
Why?
|
| Animals | 30 | 2025 | 36277 | 0.290 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 3 | 2019 | 38 | 0.290 |
Why?
|
| Hepatocytes | 2 | 2008 | 230 | 0.290 |
Why?
|
| Thyroxine | 4 | 2019 | 72 | 0.270 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 3 | 2025 | 188 | 0.270 |
Why?
|
| Thyrotropin | 4 | 2019 | 59 | 0.260 |
Why?
|
| Mice, Knockout | 8 | 2019 | 3958 | 0.230 |
Why?
|
| Protein Binding | 6 | 2015 | 1832 | 0.230 |
Why?
|
| Mice | 18 | 2023 | 18818 | 0.210 |
Why?
|
| Transcription Factors | 4 | 2025 | 2702 | 0.200 |
Why?
|
| Succinic Acid | 1 | 2022 | 15 | 0.200 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 61 | 0.190 |
Why?
|
| Orphan Nuclear Receptors | 2 | 2014 | 21 | 0.190 |
Why?
|
| Liver X Receptors | 2 | 2014 | 19 | 0.190 |
Why?
|
| Systems Analysis | 1 | 2021 | 15 | 0.190 |
Why?
|
| Triglycerides | 2 | 2021 | 613 | 0.180 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 71 | 0.180 |
Why?
|
| Introns | 1 | 2002 | 313 | 0.180 |
Why?
|
| Metabolomics | 1 | 2025 | 455 | 0.180 |
Why?
|
| Lipogenesis | 2 | 2018 | 58 | 0.180 |
Why?
|
| Fibroblast Growth Factors | 2 | 2014 | 162 | 0.180 |
Why?
|
| Hypertriglyceridemia | 1 | 2021 | 111 | 0.170 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2020 | 18 | 0.170 |
Why?
|
| Food Deprivation | 1 | 2020 | 34 | 0.170 |
Why?
|
| Glucagon | 1 | 2020 | 184 | 0.160 |
Why?
|
| Glucosides | 1 | 2020 | 48 | 0.160 |
Why?
|
| Exons | 1 | 2002 | 833 | 0.160 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2019 | 14 | 0.160 |
Why?
|
| Benzhydryl Compounds | 1 | 2020 | 68 | 0.160 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2018 | 10 | 0.150 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2018 | 8 | 0.150 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 2018 | 9 | 0.150 |
Why?
|
| Signal Transduction | 6 | 2017 | 4882 | 0.150 |
Why?
|
| Insulin | 2 | 2021 | 1246 | 0.150 |
Why?
|
| Mutation | 5 | 2017 | 6274 | 0.150 |
Why?
|
| Fructose Intolerance | 1 | 2017 | 3 | 0.150 |
Why?
|
| Glucose | 1 | 2023 | 923 | 0.140 |
Why?
|
| Transcriptome | 1 | 2025 | 1122 | 0.140 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 82 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1911 | 0.140 |
Why?
|
| Lipid Metabolism | 2 | 2025 | 378 | 0.140 |
Why?
|
| Rats | 6 | 2025 | 3874 | 0.130 |
Why?
|
| Pituitary Gland | 2 | 2014 | 88 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 3970 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2019 | 1136 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 149 | 0.120 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2014 | 244 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 122 | 0.120 |
Why?
|
| Body Weight | 1 | 2019 | 1034 | 0.120 |
Why?
|
| Gene Expression | 2 | 2011 | 1614 | 0.120 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 77 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2015 | 444 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 822 | 0.110 |
Why?
|
| Lipotropic Agents | 1 | 2014 | 6 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 216 | 0.110 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2014 | 15 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2015 | 611 | 0.110 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2014 | 60 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 480 | 0.110 |
Why?
|
| RNA, Messenger | 5 | 2021 | 2899 | 0.110 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 680 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 1632 | 0.100 |
Why?
|
| Lipids | 4 | 2023 | 567 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 4789 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 783 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 382 | 0.100 |
Why?
|
| Regeneration | 1 | 2015 | 231 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2014 | 197 | 0.100 |
Why?
|
| Ligands | 2 | 2012 | 571 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 456 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 508 | 0.100 |
Why?
|
| Retinoid X Receptors | 2 | 2010 | 32 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2003 | 295 | 0.100 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 814 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2014 | 211 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2014 | 301 | 0.100 |
Why?
|
| Chromatin | 1 | 2015 | 607 | 0.100 |
Why?
|
| Cell Line | 4 | 2015 | 2834 | 0.090 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 400 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 649 | 0.090 |
Why?
|
| Cells, Cultured | 3 | 2017 | 3162 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2011 | 118 | 0.090 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2014 | 392 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2015 | 1063 | 0.080 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2007 | 40 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 484 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2010 | 54 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2015 | 2024 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 2159 | 0.080 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2009 | 67 | 0.080 |
Why?
|
| Male | 15 | 2025 | 65712 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 298 | 0.070 |
Why?
|
| Species Specificity | 1 | 2009 | 571 | 0.070 |
Why?
|
| Base Sequence | 2 | 2003 | 3169 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1871 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 4 | 2017 | 1413 | 0.070 |
Why?
|
| Tosyl Compounds | 1 | 2007 | 24 | 0.070 |
Why?
|
| Anilides | 1 | 2007 | 59 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1405 | 0.070 |
Why?
|
| Nitriles | 1 | 2007 | 155 | 0.070 |
Why?
|
| Binding, Competitive | 2 | 2004 | 194 | 0.070 |
Why?
|
| Obesity | 1 | 2018 | 2409 | 0.060 |
Why?
|
| Acetylation | 2 | 2017 | 182 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1605 | 0.060 |
Why?
|
| Humans | 13 | 2023 | 133454 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2006 | 74 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 1070 | 0.060 |
Why?
|
| Coenzyme A | 1 | 2025 | 6 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 2007 | 433 | 0.060 |
Why?
|
| Adipocytes | 1 | 2006 | 160 | 0.060 |
Why?
|
| Hormone Antagonists | 1 | 2004 | 62 | 0.060 |
Why?
|
| Mifepristone | 1 | 2004 | 139 | 0.060 |
Why?
|
| 5' Flanking Region | 1 | 2004 | 10 | 0.060 |
Why?
|
| Nuclear Matrix | 1 | 2004 | 21 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2785 | 0.060 |
Why?
|
| Binding Sites | 2 | 2004 | 1368 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 53 | 0.050 |
Why?
|
| Succinates | 1 | 2022 | 20 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2003 | 92 | 0.050 |
Why?
|
| Transcription Initiation Site | 1 | 2002 | 34 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2022 | 50 | 0.050 |
Why?
|
| Sex Factors | 2 | 2004 | 1381 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 3055 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2021 | 122 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1304 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 912 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2002 | 371 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 561 | 0.040 |
Why?
|
| Lipolysis | 1 | 2020 | 80 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2002 | 374 | 0.040 |
Why?
|
| Calcification, Physiologic | 1 | 2019 | 24 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 396 | 0.040 |
Why?
|
| Bone Development | 1 | 2019 | 60 | 0.040 |
Why?
|
| Receptors, Somatotropin | 1 | 1998 | 9 | 0.040 |
Why?
|
| Epinephrine | 1 | 2020 | 184 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 224 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2015 | 687 | 0.040 |
Why?
|
| Rats, Zucker | 1 | 2018 | 41 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 750 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2018 | 64 | 0.040 |
Why?
|
| Intestines | 1 | 2022 | 613 | 0.040 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 1622 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 16 | 0.040 |
Why?
|
| Protein Phosphatase 2C | 1 | 2018 | 60 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 2525 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 316 | 0.030 |
Why?
|
| Female | 8 | 2018 | 71471 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 541 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 400 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 927 | 0.030 |
Why?
|
| Weight Gain | 1 | 2019 | 413 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 1998 | 335 | 0.030 |
Why?
|
| Bone Density | 1 | 2019 | 370 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 1834 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2015 | 6 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Xenopus | 1 | 2015 | 115 | 0.030 |
Why?
|
| NAD | 1 | 2015 | 46 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 93 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 808 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 1079 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2015 | 95 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 715 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2020 | 1195 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 52 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 247 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 746 | 0.030 |
Why?
|
| Protein Transport | 1 | 2015 | 387 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4745 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 643 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 2014 | 26 | 0.030 |
Why?
|
| Weight Loss | 1 | 2017 | 515 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1118 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 568 | 0.030 |
Why?
|
| Adipose Tissue, Brown | 1 | 2014 | 78 | 0.030 |
Why?
|
| Transfection | 2 | 2006 | 1086 | 0.030 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2012 | 10 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 903 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2014 | 200 | 0.020 |
Why?
|
| Genes, erbA | 1 | 2011 | 1 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5176 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4525 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1699 | 0.020 |
Why?
|
| Hormone Replacement Therapy | 1 | 2014 | 212 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 809 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 1439 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 90 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2011 | 538 | 0.020 |
Why?
|
| Cricetulus | 1 | 2007 | 96 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2014 | 1051 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1326 | 0.020 |
Why?
|
| Cricetinae | 1 | 2007 | 398 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7183 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2007 | 317 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2006 | 55 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 81 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2007 | 1101 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2006 | 262 | 0.010 |
Why?
|
| Androgens | 1 | 2007 | 292 | 0.010 |
Why?
|
| Dihydrotestosterone | 1 | 2004 | 71 | 0.010 |
Why?
|
| RNA Interference | 1 | 2006 | 540 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 711 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 1405 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1532 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 20497 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 21664 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 29299 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 1846 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3725 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 31880 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6578 | 0.010 |
Why?
|